NHP2
Basic information
Region (hg38): 5:178149463-178153894
Previous symbols: [ "NOLA2" ]
Links
Phenotypes
GenCC
Source:
- dyskeratosis congenita (Supportive), mode of inheritance: AD
- dyskeratosis congenita (Limited), mode of inheritance: AR
- dyskeratosis congenita, autosomal recessive 2 (Strong), mode of inheritance: AR
- dyskeratosis congenita, autosomal recessive 2 (Moderate), mode of inheritance: AR
- dyskeratosis congenita, autosomal recessive 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Dyskeratosis congenita, autosomal recessive 2 | AR | Allergy/Immunology/Infectious; Hematologic; Oncologic; Pulmonary | Surveillance (eg, with regularly performed CBC as well as other measures in the presence of concern for hematologic sequelae) for bone marrow failure, as well as surveillance for multiple cancer types (eg, with self-examination and clinical examination), and pulmonary disease may allow early detection and treatment; Lung transplant may be indicated in individuals with advanced lung diease; HSCT may be indicated due to manifestations including leukemia and bone marrow failure (which may also be treated with androgen therapy), but the long-term efficacy may not be optimal | Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Neurologic; Oncologic; Pulmonary | 18523010; 20301779 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- Dyskeratosis congenita, autosomal recessive 1 (1 variants)
- Dyskeratosis congenita, autosomal recessive 2 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NHP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 24 | ||||
missense | 73 | 75 | ||||
nonsense | 1 | |||||
start loss | 1 | |||||
frameshift | 9 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 6 | 9 | 15 | |||
non coding | 34 | 43 | ||||
Total | 0 | 0 | 92 | 60 | 5 |
Variants in NHP2
This is a list of pathogenic ClinVar variants found in the NHP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-178149487-C-T | Likely benign (Feb 13, 2020) | |||
5-178149702-A-T | not specified | Benign/Likely benign (May 06, 2019) | ||
5-178149705-G-A | not specified | Uncertain significance (Oct 12, 2016) | ||
5-178149709-C-T | NHP2-related disorder | Likely benign (Aug 26, 2024) | ||
5-178149715-A-C | Dyskeratosis congenita | Uncertain significance (Sep 01, 2022) | ||
5-178149715-A-T | Dyskeratosis congenita, autosomal recessive 2 • Dyskeratosis congenita, autosomal recessive 1 | Pathogenic (Aug 01, 2017) | ||
5-178149719-G-T | Dyskeratosis congenita | Likely benign (Aug 23, 2022) | ||
5-178149720-G-A | Dyskeratosis congenita | Uncertain significance (Oct 03, 2022) | ||
5-178149726-G-T | Dyskeratosis congenita | Uncertain significance (Jun 03, 2022) | ||
5-178149728-C-T | Dyskeratosis congenita | Likely benign (Sep 15, 2021) | ||
5-178149734-C-A | Dyskeratosis congenita | Uncertain significance (Nov 06, 2023) | ||
5-178149736-G-A | Dyskeratosis congenita | Uncertain significance (Jan 26, 2023) | ||
5-178149736-G-T | Dyskeratosis congenita | Uncertain significance (Oct 13, 2023) | ||
5-178149739-C-G | Dyskeratosis congenita | Uncertain significance (May 10, 2022) | ||
5-178149741-T-A | Dyskeratosis congenita | Uncertain significance (Aug 19, 2022) | ||
5-178149753-T-C | Dyskeratosis congenita | Uncertain significance (Mar 04, 2022) | ||
5-178149757-C-T | Dyskeratosis congenita | Uncertain significance (Feb 16, 2022) | ||
5-178149758-G-A | Dyskeratosis congenita | Likely benign (Oct 03, 2023) | ||
5-178149760-A-G | Dyskeratosis congenita, autosomal recessive 2 • Dyskeratosis congenita, autosomal recessive 1 | Pathogenic (Jun 10, 2008) | ||
5-178149772-ACTC-A | Dyskeratosis congenita | Uncertain significance (Apr 02, 2019) | ||
5-178149778-C-T | Dyskeratosis congenita | Uncertain significance (Aug 30, 2023) | ||
5-178149779-A-ATGGGGCTT | Dyskeratosis congenita | Uncertain significance (Jan 22, 2018) | ||
5-178149781-G-A | Dyskeratosis congenita • Dyskeratosis congenita, autosomal recessive 2 | Uncertain significance (Aug 09, 2022) | ||
5-178149784-G-T | Dyskeratosis congenita | Uncertain significance (Sep 04, 2023) | ||
5-178149792-A-G | Dyskeratosis congenita | Uncertain significance (Aug 30, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NHP2 | protein_coding | protein_coding | ENST00000274606 | 4 | 4508 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0501 | 0.868 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0376 | 87 | 88.0 | 0.989 | 0.00000419 | 976 |
Missense in Polyphen | 33 | 30.794 | 1.0716 | 379 | ||
Synonymous | 0.00556 | 36 | 36.0 | 0.999 | 0.00000171 | 307 |
Loss of Function | 1.44 | 3 | 7.15 | 0.419 | 3.92e-7 | 87 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000405 | 0.000405 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000220 | 0.000220 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ("psi") residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme. {ECO:0000269|PubMed:15044956}.;
- Disease
- DISEASE: Dyskeratosis congenita, autosomal recessive, 2 (DKCB2) [MIM:613987]: A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy. {ECO:0000269|PubMed:18523010}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Ribosome biogenesis in eukaryotes - Homo sapiens (human);rRNA processing;Metabolism of RNA;Telomere Extension By Telomerase;Extension of Telomeres;Telomere Maintenance;Chromosome Maintenance;Cell Cycle;rRNA modification in the nucleus and cytosol;rRNA processing in the nucleus and cytosol
(Consensus)
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- loftool
- 0.729
- rvis_EVS
- 0.42
- rvis_percentile_EVS
- 76.81
Haploinsufficiency Scores
- pHI
- 0.604
- hipred
- Y
- hipred_score
- 0.796
- ghis
- 0.579
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.520
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nhp2
- Phenotype
- skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- cleavage involved in rRNA processing;maturation of LSU-rRNA;telomere maintenance via telomerase;rRNA pseudouridine synthesis;snRNA pseudouridine synthesis;positive regulation of telomerase RNA localization to Cajal body
- Cellular component
- nuclear chromosome, telomeric region;nucleoplasm;telomerase holoenzyme complex;small nucleolar ribonucleoprotein complex;box H/ACA snoRNP complex;box H/ACA scaRNP complex;box H/ACA telomerase RNP complex
- Molecular function
- RNA binding;protein binding;box H/ACA snoRNA binding;telomerase RNA binding